Bvf Inc/Il insider trades: MoonLake Immunotherapeutics (MLTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bvf Inc/Il reports to the SEC
and 52 more companies
Open-market buys and sales
293 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | MLTX | ↓ Sell | 3,750,000 | $16.79 | $63.0M | Direct | Apr 2, 2026 (2d) |
| Aug 5, 2025 | EPIX | ↓ Sell | 156 | $1.88 | $293 | Direct | Aug 7, 2025 (2d) |
| Jun 30, 2025 | KYMR | ↑ Buy | 317,167 | $44.00 | $14.0M | Direct | Jul 1, 2025 (1d) |
| May 16, 2025 | XOMA | ↓ Sell | 392,723 | $27.10 | $10.6M | Direct | May 20, 2025 (4d) |
| Jan 24, 2025 | XOMA | ↓ Sell | 500,742 | $26.10 | $13.1M | Direct | Jan 28, 2025 (4d) |
| Jan 24, 2025 | XOMA | ↓ Sell | 149,975 | $26.10 | $3.9M | Indirect | Jan 28, 2025 (4d) |
| Oct 29, 2024 | THRD | ↓ Sell | 1,000,000 | $14.30 | $14.3M | Direct | Oct 31, 2024 (2d) |
| Oct 4, 2024 | MLTX | ↓ Sell | 2,000,000 | $50.00 | $100.0M | Direct | Oct 8, 2024 (4d) |
| Dec 18, 2023 | PNT | ↓ Sell | 17,161,278 | $12.45 | $213.7M | Direct | Dec 20, 2023 (2d) |
| Nov 16, 2023 | RPTX | ↑ Buy | 1,227,301 | $5.09 | $6.2M | Direct | Nov 17, 2023 (1d) |
| Nov 3, 2023 | KYMR | ↑ Buy | 414,105 | $12.80 | $5.3M | Direct | Nov 6, 2023 (3d) |
| Nov 2, 2023 | RPTX | ↑ Buy | 783,709 | $3.60 | $2.8M | Direct | Nov 3, 2023 (1d) |
| Sep 12, 2023 | OLMA | ↑ Buy | 1,505,932 | $9.84 | $14.8M | Direct | Sep 14, 2023 (2d) |
| Jan 12, 2023 | KYMR | ↑ Buy | 41,007 | $30.51 | $1.3M | Direct | Jan 13, 2023 (1d) |
| Jan 6, 2023 | XOMA | ↑ Buy | 22,249 | $18.91 | $421K | Direct | Jan 9, 2023 (3d) |
| Dec 20, 2022 | THRD | ↑ Buy | 214,063 | $4.11 | $879K | Direct | Dec 22, 2022 (2d) |
| Nov 8, 2022 | RAIN | ↑ Buy | 1,710,358 | $5.83 | $10.0M | Direct | Nov 10, 2022 (2d) |
| Sep 27, 2022 | XOMA | ↑ Buy | 24,642 | $16.61 | $409K | Direct | Sep 27, 2022 (0d) |
| Sep 16, 2022 | XOMA | ↑ Buy | 56,309 | $17.59 | $991K | Direct | Sep 16, 2022 (0d) |
| Aug 22, 2022 | KYMR | ↑ Buy | 545,525 | $26.00 | $14.2M | Direct | Aug 23, 2022 (1d) |
| Aug 9, 2022 | CTIC | ↓ Sell | 7,210,566 | $6.12 | $44.1M | Direct | Aug 11, 2022 (2d) |
| Aug 9, 2022 | CTIC | ↓ Sell | 1,289,434 | $6.12 | $7.9M | Indirect | Aug 11, 2022 (2d) |
| Jun 13, 2022 | RPTX | ↑ Buy | 149,161 | $12.73 | $1.9M | Direct | Jun 15, 2022 (2d) |
| Jun 10, 2022 | OLMA | ↑ Buy | 200,000 | $4.03 | $807K | Direct | Jun 14, 2022 (4d) |
| Jun 6, 2022 | RPTX | ↑ Buy | 1,836,958 | $11.90 | $21.9M | Direct | Jun 6, 2022 (0d) |
| Jun 1, 2022 | CGEM | ↑ Buy | 751,396 | $11.00 | $8.3M | Direct | Jun 3, 2022 (2d) |
| May 27, 2022 | KYMR | ↑ Buy | 289,426 | $14.34 | $4.2M | Direct | May 31, 2022 (4d) |
| May 20, 2022 | KYMR | ↑ Buy | 10,100 | $14.00 | $141K | Direct | May 24, 2022 (4d) |
| May 18, 2022 | RPTX | ↑ Buy | 420,000 | $8.50 | $3.6M | Direct | May 20, 2022 (2d) |
| May 13, 2022 | CGEM | ↑ Buy | 1,109,900 | $9.07 | $10.1M | Direct | May 16, 2022 (3d) |
| May 6, 2022 | KYMR | ↑ Buy | 250,000 | $19.46 | $4.9M | Direct | May 9, 2022 (3d) |
| Apr 1, 2022 | CGEM | ↑ Buy | 276,000 | $10.75 | $3.0M | Direct | Apr 5, 2022 (4d) |
| Jan 31, 2022 | KYMR | ↑ Buy | 130,309 | $38.96 | $5.1M | Direct | Jan 31, 2022 (0d) |
| Jan 24, 2022 | KYMR | ↑ Buy | 272,767 | $37.76 | $10.3M | Direct | Jan 26, 2022 (2d) |
| Jan 19, 2022 | RPTX | ↑ Buy | 997,961 | $14.10 | $14.1M | Direct | Jan 21, 2022 (2d) |
| Jan 7, 2022 | RAIN | ↑ Buy | 557,728 | $12.00 | $6.7M | Direct | Jan 10, 2022 (3d) |
| Nov 30, 2021 | OLMA | ↑ Buy | 739,675 | $9.39 | $6.9M | Direct | Dec 2, 2021 (2d) |
| Oct 8, 2021 | MRUS | ↓ Sell | 1,132,714 | $27.56 | $31.2M | Direct | Oct 8, 2021 (0d) |
| Sep 21, 2021 | RAIN | ↑ Buy | 11,033 | $13.94 | $154K | Direct | Sep 23, 2021 (2d) |
| Sep 13, 2021 | RAIN | ↑ Buy | 392,269 | $16.49 | $6.5M | Direct | Sep 15, 2021 (2d) |
| Jul 6, 2021 | RAIN | ↑ Buy | 587,002 | $15.47 | $9.1M | Direct | Jul 6, 2021 (0d) |
| Jul 2, 2021 | MRUS | ↓ Sell | 2,186,022 | $20.75 | $45.4M | Direct | Jul 7, 2021 (5d) |
| Jul 1, 2021 | KYMR | ↑ Buy | 544,166 | $47.00 | $25.6M | Direct | Jul 6, 2021 (5d) |
| May 24, 2021 | RAIN | ↑ Buy | 123,347 | $15.94 | $2.0M | Direct | May 25, 2021 (1d) |
| May 19, 2021 | RAIN | ↑ Buy | 208,465 | $16.59 | $3.5M | Direct | May 20, 2021 (1d) |
| May 13, 2021 | RAIN | ↑ Buy | 58,000 | $14.26 | $827K | Direct | May 17, 2021 (4d) |
| Apr 1, 2021 | CTIC | ↑ Buy | 2,000,000 | $2.50 | $5.0M | Direct | Apr 5, 2021 (4d) |
| Mar 31, 2021 | XOMA | ↓ Sell | 569,797 | $38.36 | $21.9M | Direct | Apr 2, 2021 (2d) |
| Mar 31, 2021 | XOMA | ↓ Sell | 81,903 | $38.36 | $3.1M | Indirect | Apr 2, 2021 (2d) |
| Mar 30, 2021 | MRUS | ↑ Buy | 300,000 | $19.75 | $5.9M | Direct | Apr 1, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLTX insiders
Open-market trades in the last 12 months
About Bvf Inc/Il's insider trades
Bvf Inc/Il is a director at MoonLake Immunotherapeutics (MLTX). Since Jan 13, 2006, it has reported 212 open-market purchases worth $570.2M and 81 sales worth $1.06B on SEC Form 4. In the last 12 months: 1 sale ($63.0M).
Its filings also include other transactions (33 filings), grants and awards (27 filings), conversions (8 filings), shares returned to the company (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.